Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
756.9 USD | -2.56% | +4.39% | +29.81% |
02:24pm | Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1 | RE |
07:42am | Obesity drugmaker Novo Nordisk raises outlook, Q1 profit beats forecast | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.81% | 699B | |
+25.07% | 571B | |
-4.82% | 364B | |
+17.76% | 326B | |
+3.41% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.80% | 154B | |
-3.58% | 149B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Morgan Stanley Adjusts Price Target on Eli Lilly to $455 From $440, Maintains Overweight Rating